Vaccine News and Research

Latest Vaccine News and Research

Scientists discover new strategy to fight back against norovirus

Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide.

6 Mar 2025

New antibody pair could defeat all SARS-CoV-2 variants

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep pace with evolving viruses.

6 Mar 2025

Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liver

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized.

5 Mar 2025

CDC firings undermine public health work far beyond Washington

The Trump administration’s sudden firing of Centers for Disease Control and Prevention employees gutted training programs across the nation whose participants bolstered the workforce of state and local public health departments that for decades have been starved of resources.

5 Mar 2025

HPV more common in men than women and linked to rising cancer rates

While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that the virus is actually more common among men than women and is associated with rising rates of other cancers that directly impact men.

4 Mar 2025

Investigating genetic differences in Listeria strains used for listeriosis vaccine

Announcing a new article publication for Zoonoses journal. Listeriosis is among the most severe food-borne diseases affecting both animals and humans, and it presents a serious threat to public health, animal welfare, and the food industry.

27 Feb 2025

Cambridge launches program to tackle engineered pandemic risks

Covid-19 showed us how vulnerable the world is to pandemics – but what if the next pandemic were somehow engineered? How would the world respond – and could we stop it happening in the first place?

27 Feb 2025

WHO Director-General issues revised recommendations on mpox emergency

The Director-General of the World Health Organization (WHO), following the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the upsurge of mpox 2024, held on 25 February 2025, from 12:00 to 17:00 CET, concurs with its advice that the event continues to meet the criteria of a public health emergency of international concern and, considering the advice of the Committee, he is hereby issuing a revised set of temporary recommendations.

27 Feb 2025

Study highlights increase in VZV-induced CNS infections and dementia risk

Researchers from Fujita Health University, Japan, observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster virus (VZV), post-2019. The researchers highlighted the potential of zoster vaccination to reduce CNS infections.

27 Feb 2025

Researchers create mycobacteria with kill switches to improve TB vaccine safety

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the bacteria after they activate an immune response.

25 Feb 2025

Machine learning algorithm decodes immune system’s hidden data for disease detection

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of baddies.

24 Feb 2025

T cells play key role in protecting children from severe dengue

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).

24 Feb 2025

Why over 5 billion people still lack access to life-saving medical oxygen

The Lancet Global Health Commission highlights severe inequities in medical oxygen access, urging systemic reforms to ensure universal availability and affordability.

23 Feb 2025

Discovery paves way for new hepatitis B treatment

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine, and The Rockefeller University identified a vulnerability that opens the door to new treatments.

22 Feb 2025

New human antibody shows promise for Ebola virus treatment

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.

21 Feb 2025

Africa faces growing cholera crisis amid underfunded control plans

Climate change and conflict are fuelling a resurgence of cholera in Africa, with progress toward elimination undermined by chronic underfunding, according to new analysis.

21 Feb 2025

Targeted mRNA therapy shows promise for healing damaged lungs

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

21 Feb 2025

Texas measles outbreak nears 100 cases, raising concerns about undetected spread

Some private schools have shut down because of a rapidly escalating measles outbreak in West Texas. Local health departments are overstretched, pausing other important work as they race to limit the spread of this highly contagious virus.

21 Feb 2025

Breakthrough discovery unveils potential treatment for hepatitis B

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine and The Rockefeller University identified a vulnerability that opens the door to new treatments.

20 Feb 2025